We investigated ALK, STAT3 and MYCN levels in CLB-GE, CLB-BAR, Kelly and CLB-GA neuroblastoma cell lines upon treatment with STAT3 inhibitors (Fig. 4A–D). The gene discussed is STAT3; the disease is neuroblastoma.